US Stock MarketDetailed Quotes

Sutro Biopharma (STRO)

Watchlist
  • 26.480
  • +0.390+1.49%
Close Jun 11 16:00 ET
  • 26.480
  • 0.0000.00%
Post 20:01 ET
438.79MMarket Cap-1.62P/E (TTM)

Sutro Biopharma (STRO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
37.75%-42.26M
7.47%-177.23M
63.15%-26.44M
40.81%-38.19M
-573.02%-44.72M
-4.85%-67.88M
-71.61%-191.54M
-609.79%-71.74M
-92.57%-64.52M
130.31%9.46M
Net income from continuing operations
49.34%-38.48M
15.99%-191.09M
35.45%-46.76M
-16.54%-56.86M
76.05%-11.5M
-30.50%-75.97M
-112.99%-227.46M
-333.20%-72.44M
1.01%-48.79M
-24.64%-48.02M
Operating gains losses
----
----
----
----
----
----
---32.14M
--0
----
----
Depreciation and amortization
-32.74%1.28M
1.47%7.32M
-13.06%1.62M
5.61%1.9M
6.15%1.9M
7.89%1.9M
5.90%7.22M
7.91%1.87M
3.45%1.8M
3.41%1.79M
Other non cash items
-1.26%10.77M
20.80%44.66M
9.91%11.21M
20.50%11.32M
27.74%11.23M
26.94%10.91M
119.82%36.97M
34.49%10.2M
27.21%9.4M
617.39%8.79M
Change In working capital
-85.24%-16.94M
-666.28%-50.4M
129.74%4.68M
165.29%4.65M
-204.57%-50.58M
44.96%-9.15M
125.89%8.9M
27.09%-15.74M
-290.27%-7.12M
514.23%48.37M
-Change in receivables
-72.00%-8.51M
-83.11%4.64M
97.20%-55K
1,282.03%4.08M
-77.15%5.56M
-203.52%-4.95M
194.84%27.46M
89.92%-1.96M
104.45%295K
19,425.40%24.35M
-Change in prepaid assets
-9,218.18%-1M
267.42%19.35M
171.81%4.98M
412.50%7.95M
1,994.77%6.41M
100.46%11K
-10,703.67%-11.56M
-935.72%-6.93M
-393.20%-2.55M
-95.83%306K
-Change in payables and accrued expense
59.48%5.86M
116.31%1.08M
-85.31%496K
40.89%-798K
61.98%-2.29M
237.94%3.67M
-122.08%-6.65M
-86.37%3.38M
-127.88%-1.35M
-323.37%-6.01M
-Change in other current liabilities
-16.22%-2.04M
-16.51%-7.48M
-16.20%-1.99M
-16.25%-1.93M
-16.76%-1.8M
-16.90%-1.76M
-40.02%-6.42M
-16.80%-1.71M
-16.88%-1.66M
-79.23%-1.55M
-Change in other working capital
-83.58%-11.25M
-1,221.24%-67.99M
114.67%1.25M
-150.32%-4.65M
-286.95%-58.46M
58.72%-6.13M
119.53%6.06M
65.64%-8.51M
-130.55%-1.86M
2,788.99%31.27M
Cash from discontinued investing activities
Operating cash flow
37.75%-42.26M
7.47%-177.23M
63.15%-26.44M
40.81%-38.19M
-573.02%-44.72M
-4.85%-67.88M
-71.61%-191.54M
-609.79%-71.74M
-92.57%-64.52M
130.31%9.46M
Investing cash flow
Cash flow from continuing investing activities
-178.41%-45.26M
-79.40%45.01M
-78.62%18.7M
-72.85%39.99M
103.21%2.58M
-125.36%-16.26M
5,668.50%218.51M
472.08%87.49M
229.18%147.29M
-221.49%-80.38M
Net PPE purchase and sale
99.06%-11K
45.29%-1.7M
82.77%-184K
69.69%-251K
88.62%-86K
-163.23%-1.17M
28.20%-3.1M
25.88%-1.07M
-152.44%-828K
52.87%-756K
Net investment purchase and sale
-200.01%-45.25M
-78.92%46.71M
-78.67%18.89M
-72.83%40.24M
103.35%2.67M
-123.37%-15.08M
56,576.73%221.61M
501.21%88.56M
230.28%148.12M
-217.50%-79.62M
Cash from discontinued investing activities
Investing cash flow
-178.41%-45.26M
-79.40%45.01M
-78.62%18.7M
-72.85%39.99M
103.21%2.58M
-125.36%-16.26M
5,668.50%218.51M
472.08%87.49M
229.18%147.29M
-221.49%-80.38M
Financing cash flow
Cash flow from continuing financing activities
156,074.24%103.08M
-99.95%44K
-166.67%-64K
-89.97%102K
-100.06%-60K
101.92%66K
-31.62%94.05M
99.23%-24K
117.72%1.02M
-29.91%96.49M
Net issuance payments of debt
----
--0
--0
--0
--0
--0
67.34%-4.08M
--0
--0
--0
Net common stock issuance
--103.13M
--0
--0
--0
--0
--0
706.34%96.53M
--0
--0
9,110.59%96.53M
Proceeds from stock option exercised by employees
-55.69%109K
-82.26%376K
--3K
-88.36%127K
--0
-76.07%246K
-10.40%2.12M
--0
14.36%1.09M
--0
Net other financing activities
11.11%-160K
34.77%-332K
-179.17%-67K
66.22%-25K
-62.16%-60K
51.87%-180K
-100.38%-509K
---24K
97.93%-74K
-100.03%-37K
Cash from discontinued financing activities
Financing cash flow
156,074.24%103.08M
-99.95%44K
-166.67%-64K
-89.97%102K
-100.06%-60K
101.92%66K
-31.62%94.05M
99.23%-24K
117.72%1.02M
-29.91%96.49M
Net cash flow
Beginning cash position
-69.14%58.99M
172.54%191.16M
-61.93%66.79M
-29.20%64.88M
62.07%107.09M
172.54%191.16M
45.74%70.14M
112.12%175.44M
-61.16%91.65M
4.31%66.08M
Current changes in cash
118.50%15.55M
-209.21%-132.17M
-149.58%-7.8M
-97.73%1.9M
-265.05%-42.2M
-1,968.27%-84.08M
449.75%121.02M
225.15%15.73M
154.67%83.79M
-85.19%25.57M
End cash Position
-30.39%74.54M
-69.14%58.99M
-69.14%58.99M
-61.93%66.79M
-29.20%64.88M
62.07%107.09M
172.54%191.16M
172.54%191.16M
112.12%175.44M
-61.16%91.65M
Free cash flow
38.79%-42.27M
8.07%-178.93M
63.44%-26.62M
41.17%-38.44M
-615.12%-44.81M
-5.94%-69.06M
-67.89%-194.64M
-676.41%-72.81M
-93.15%-65.34M
126.52%8.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 37.75%-42.26M7.47%-177.23M63.15%-26.44M40.81%-38.19M-573.02%-44.72M-4.85%-67.88M-71.61%-191.54M-609.79%-71.74M-92.57%-64.52M130.31%9.46M
Net income from continuing operations 49.34%-38.48M15.99%-191.09M35.45%-46.76M-16.54%-56.86M76.05%-11.5M-30.50%-75.97M-112.99%-227.46M-333.20%-72.44M1.01%-48.79M-24.64%-48.02M
Operating gains losses ---------------------------32.14M--0--------
Depreciation and amortization -32.74%1.28M1.47%7.32M-13.06%1.62M5.61%1.9M6.15%1.9M7.89%1.9M5.90%7.22M7.91%1.87M3.45%1.8M3.41%1.79M
Other non cash items -1.26%10.77M20.80%44.66M9.91%11.21M20.50%11.32M27.74%11.23M26.94%10.91M119.82%36.97M34.49%10.2M27.21%9.4M617.39%8.79M
Change In working capital -85.24%-16.94M-666.28%-50.4M129.74%4.68M165.29%4.65M-204.57%-50.58M44.96%-9.15M125.89%8.9M27.09%-15.74M-290.27%-7.12M514.23%48.37M
-Change in receivables -72.00%-8.51M-83.11%4.64M97.20%-55K1,282.03%4.08M-77.15%5.56M-203.52%-4.95M194.84%27.46M89.92%-1.96M104.45%295K19,425.40%24.35M
-Change in prepaid assets -9,218.18%-1M267.42%19.35M171.81%4.98M412.50%7.95M1,994.77%6.41M100.46%11K-10,703.67%-11.56M-935.72%-6.93M-393.20%-2.55M-95.83%306K
-Change in payables and accrued expense 59.48%5.86M116.31%1.08M-85.31%496K40.89%-798K61.98%-2.29M237.94%3.67M-122.08%-6.65M-86.37%3.38M-127.88%-1.35M-323.37%-6.01M
-Change in other current liabilities -16.22%-2.04M-16.51%-7.48M-16.20%-1.99M-16.25%-1.93M-16.76%-1.8M-16.90%-1.76M-40.02%-6.42M-16.80%-1.71M-16.88%-1.66M-79.23%-1.55M
-Change in other working capital -83.58%-11.25M-1,221.24%-67.99M114.67%1.25M-150.32%-4.65M-286.95%-58.46M58.72%-6.13M119.53%6.06M65.64%-8.51M-130.55%-1.86M2,788.99%31.27M
Cash from discontinued investing activities
Operating cash flow 37.75%-42.26M7.47%-177.23M63.15%-26.44M40.81%-38.19M-573.02%-44.72M-4.85%-67.88M-71.61%-191.54M-609.79%-71.74M-92.57%-64.52M130.31%9.46M
Investing cash flow
Cash flow from continuing investing activities -178.41%-45.26M-79.40%45.01M-78.62%18.7M-72.85%39.99M103.21%2.58M-125.36%-16.26M5,668.50%218.51M472.08%87.49M229.18%147.29M-221.49%-80.38M
Net PPE purchase and sale 99.06%-11K45.29%-1.7M82.77%-184K69.69%-251K88.62%-86K-163.23%-1.17M28.20%-3.1M25.88%-1.07M-152.44%-828K52.87%-756K
Net investment purchase and sale -200.01%-45.25M-78.92%46.71M-78.67%18.89M-72.83%40.24M103.35%2.67M-123.37%-15.08M56,576.73%221.61M501.21%88.56M230.28%148.12M-217.50%-79.62M
Cash from discontinued investing activities
Investing cash flow -178.41%-45.26M-79.40%45.01M-78.62%18.7M-72.85%39.99M103.21%2.58M-125.36%-16.26M5,668.50%218.51M472.08%87.49M229.18%147.29M-221.49%-80.38M
Financing cash flow
Cash flow from continuing financing activities 156,074.24%103.08M-99.95%44K-166.67%-64K-89.97%102K-100.06%-60K101.92%66K-31.62%94.05M99.23%-24K117.72%1.02M-29.91%96.49M
Net issuance payments of debt ------0--0--0--0--067.34%-4.08M--0--0--0
Net common stock issuance --103.13M--0--0--0--0--0706.34%96.53M--0--09,110.59%96.53M
Proceeds from stock option exercised by employees -55.69%109K-82.26%376K--3K-88.36%127K--0-76.07%246K-10.40%2.12M--014.36%1.09M--0
Net other financing activities 11.11%-160K34.77%-332K-179.17%-67K66.22%-25K-62.16%-60K51.87%-180K-100.38%-509K---24K97.93%-74K-100.03%-37K
Cash from discontinued financing activities
Financing cash flow 156,074.24%103.08M-99.95%44K-166.67%-64K-89.97%102K-100.06%-60K101.92%66K-31.62%94.05M99.23%-24K117.72%1.02M-29.91%96.49M
Net cash flow
Beginning cash position -69.14%58.99M172.54%191.16M-61.93%66.79M-29.20%64.88M62.07%107.09M172.54%191.16M45.74%70.14M112.12%175.44M-61.16%91.65M4.31%66.08M
Current changes in cash 118.50%15.55M-209.21%-132.17M-149.58%-7.8M-97.73%1.9M-265.05%-42.2M-1,968.27%-84.08M449.75%121.02M225.15%15.73M154.67%83.79M-85.19%25.57M
End cash Position -30.39%74.54M-69.14%58.99M-69.14%58.99M-61.93%66.79M-29.20%64.88M62.07%107.09M172.54%191.16M172.54%191.16M112.12%175.44M-61.16%91.65M
Free cash flow 38.79%-42.27M8.07%-178.93M63.44%-26.62M41.17%-38.44M-615.12%-44.81M-5.94%-69.06M-67.89%-194.64M-676.41%-72.81M-93.15%-65.34M126.52%8.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran conflict shows signs of easing. On the 11th, Eastern Time, Trump revealed that the United States and Iran are expected to reac Show More